IL-17 has been implicated in the promotion of lung cancer growth, in part by fostering a pro-inflammatory environment that leads to tumor cell proliferation, angiogenesis, and the recruitment of bone marrow-derived cells (122, 126). Here, IL17A is linked to lung cancer.